ABSTRACT
Objective To describe the development of an area-level measure of children’s opportunity, the Ohio Children’s Opportunity Index (OCOI).
Data Sources/Study Setting Secondary data were collected from US census based-American Community Survey (ACS), US Environmental Protection Agency, US Housing and Urban Development, Ohio Vital Statistics, US Department of Agriculture-Economic Research Service, Ohio State University Center for Urban and Regional Analysis, Ohio Incident Based Reporting System, IPUMS National Historical Geographic Information System, and Ohio Department of Medicaid.
Study Design OCOI domains were selected based on existing literature, which included family stability, infant health, children’s health, access, education, housing, environment and criminal justice domains. The composite index was developed using an equal weighting approach. Validation analyses were conducted between OCOI and health and race-related outcomes.
Data Collection/Extraction Methods Data were aggregated at the census tract level.
Principal Findings Composite OCOI scores ranged from 0-100 with an average value of 74.82 (SD, 17.00), was negatively skewed. Census tracts in the major metropolitan cities across Ohio represented 76% of the total census tracts in the least advantaged OCOI septile. OCOI served as a significant predictor of health and race-related outcomes. The average life expectancy at birth of children born in the most advantaged septile was approximately nine years more than those born in the least advantaged septile. Increases in OCOI were associated with decreases in proportion of Black (48 points lower in the most advantaged vs least advantaged septile), p<0.001) and Minority populations (54 points lower in most advantaged vs least advantaged septile, p<0.001).
Conclusion As the first opportunity index developed for children in Ohio, the OCOI is a valuable resource for policy reform, especially related to health equity. Health care providers can use it to obtain more holistic views on their patients and implement interventions that can tackle barriers to childhood development.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The project is sponsored by the Ohio Departments of Higher Education and Medicaid and funded in part by the Ohio Medicaid Technical Assistance And Policy Program.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Our study was reviewed by The Ohio State University Institutional Review Board and ethical approval was waived.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email: Naleef.Fareed{at}osumc.edu
Email: Priti.Singh{at}osumc.edu
Email: Pallavi.Jonnalagadda{at}osumc.edu
Email: Christine.Swoboda{at}osumc.edu
Email: Colin.Odden{at}osumc.edu
Email: Nathan.Doogan{at}osumc.edu
Disclosure Statement: All authors declare no commercial associations or conflicts of interest.
Funding Details: The project is sponsored by the Ohio Departments of Higher Education and Medicaid and funded in part by the Ohio Medicaid Technical Assistance And Policy Program.
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.